ANNEXATM-R: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, DEMONSTRATING REVERSAL OF RIVAROXABAN-INDUCED ANTICOAGULATION IN OLDER SUBJECTS BY ANDEXANET ALFA (PRT064445), A UNIVERSAL ANTIDOTE FOR FACTOR XA (FXA) INHIBITORS Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gold, Alexander Michael
  • Crowther, Mark
  • Levy, Gallia
  • Lu, Genmin
  • Leeds, Janet
  • Barron, Lee
  • Conley, Pamela
  • Castillo, Janice
  • Curnutte, John
  • Connolly, Stuart

publication date

  • March 2015